From ChatGPT to BloombergGPT: In capital markets, who can make the most of large language models?

Capital markets are no strangers to hype machines. Among the buzz around generative AI, Nyela wonders who will be best suited to take advantage of the technology and deliver the right use cases to Wall Street.

Artificial intelligence’s boogeyman status in the cultural zeitgeist is due in large part, I believe, to James Cameron’s 1984 sci-fi classic, The Terminator. In the film, Arnold Schwarzenegger plays the titular character, a cyborg from the year 2029, who is sent back in time to the 1980s by Skynet, a malicious artificial intelligence network that has gained self-awareness. The Terminator’s mission is to kill a woman named Sarah Connor because her future son, John, will lead a resistance movement

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Systematic tools gain favor in fixed income

Automation is enabling systematic strategies in fixed income that were previously reserved for equities trading. The tech gap between the two may be closing, but differences remain.

Why recent failures are a catalyst for DLT’s success

Deutsche Bank’s Mathew Kathayanat and Jie Yi Lee argue that DLT's high-profile failures don't mean the technology is dead. Now that the hype has died down, the path is cleared for more measured decisions about DLT’s applications.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here